Company Profile
Black Diamond Therapeutics Stock Price, News & Analysis
- Ticker:
- BDTX
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Black Diamond Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Stock performance
1.61 USD (0.00%)
Close
Last updated: June 23, 2026 at 00:00
92.26M USD
Market cap
Why the stock is moving
BDTX is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Black Diamond Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Black Diamond Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts.
Business Model Characteristics
Black Diamond Therapeutics follows a pipeline-led model where clinical readouts, filing updates, and program expansion determine how the market underwrites the story.
Position Within the Biotechnology Landscape
Compared with more mature healthcare names, Black Diamond Therapeutics sits on the development side of the biotech landscape, where catalyst timing can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
Black Diamond Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Source: Black Diamond Therapeutics
- 04
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
Source: Black Diamond Therapeutics
- 05
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference
Source: Black Diamond Therapeutics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Black Diamond Therapeutics (BDTX)?
Black Diamond Therapeutics (BDTX) most recently closed at 1.61 USD, a 0.00% move versus the previous session.
What is the market cap of Black Diamond Therapeutics (BDTX)?
Black Diamond Therapeutics currently has a market capitalization of 92.26M USD on BioPharmSignal.
What does Black Diamond Therapeutics do?
Black Diamond Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
On which exchange is BDTX stock listed?
Black Diamond Therapeutics (BDTX) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Black Diamond Therapeutics is followed within the biopharmaceutical universe for its exposure to pipeline and commercialization catalysts., Biotechnology.
What is Black?
Black Diamond Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
Which conditions is Black Diamond Therapeutics targeting with Black?
Black Diamond Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Diamond?
Black Diamond Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.
What is Therapeutics?
Black Diamond Therapeutics is a biopharmaceutical company focused on pipeline execution and catalyst-driven growth, with investors tracking how data, regulatory milestones, and launch timing reshape the investment case.